“New Opportunities in Haemophilia Treatment: Efmoroctocog Alfa for Patients With Haemophilia A ”. Epidemiology, Biostatistics, and Public Health, vol. 16, no. 4, Jan. 2022, https://doi.org/10.2427/13247.